The specific alterations identified, such as the modulation of positive and negative regulation of autophagy, as well as changes in cellular components and processes related to autophagosome function, provide valuable insights into the intricate relationship between IDH1 mutation and the dysregulation of autophagy pathways in glioma. The gene discussed is IDH1; the disease is central nervous system cancer.